The European Reference Network on Genetic Tumour Risk Syndromes (ERN GENTURIS): benefits for patients, families, and health care providers
The European Reference Network on Genetic Tumour Risk Syndromes (ERN GENTURIS) established in 2017 and connecting more than 50 European expert centres improves access to diagnosis, treatment, and the provision of high-quality healthcare for patients with rare genetic tumour risk syndromes (hereditary cancer), no matter where they live in Europe.
Authors
- Nicoline Hoogerbrugge (ORCID: https://orcid.org/0000-0003-2393-8141)
- Jurriaan Hölzenspies (ORCID: https://orcid.org/0000-0002-0805-5263)
- N.A. Geverink
- Manon Engels (ORCID: https://orcid.org/0000-0001-9035-6876)
- Claas Röhl (ORCID: https://orcid.org/0000-0003-0320-9435)
- Katarzyna Urbańczyk
Institutions
- Radboud University Nijmegen (NL)
- Radboud University Medical Center (NL)
- Radboud Institute for Molecular Life Sciences (NL)
- St Anna Children's Hospital (AT)
Publication Details
- Journal
- Familial Cancer
- Published
- 2025-03-30
- DOI
- https://doi.org/10.1007/s10689-025-00457-9
- Citations
- 3
- Primary Topic
- BRCA gene mutations in cancer
- Type
- article
- Field-Weighted Citation Impact
- 5.45
Funders
- European Commission
- European Organisation for Rare Diseases